These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 32275118)
21. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma. Yang Z; Flores J; Katz S; Nathan CA; Mehta V Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057 [TBL] [Abstract][Full Text] [Related]
22. Controversies in the surgical management of differentiated thyroid carcinoma. Noguchi M; Katev N; Miyazaki I Int Surg; 1996; 81(2):163-7. PubMed ID: 8912084 [TBL] [Abstract][Full Text] [Related]
23. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients. Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109 [TBL] [Abstract][Full Text] [Related]
24. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer. Sung TY; Jeon MJ; Lee YH; Lee YM; Kwon H; Yoon JH; Chung KW; Kim WG; Song DE; Hong SJ J Clin Endocrinol Metab; 2017 Mar; 102(3):793-800. PubMed ID: 27809646 [TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases. Bal CS; Garg A; Chopra S; Ballal S; Soundararajan R J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):745-51. PubMed ID: 25210762 [TBL] [Abstract][Full Text] [Related]
26. Papillary and Follicular Thyroid Cancer in children and adolescents: Current approach and future directions. Bauer AJ Semin Pediatr Surg; 2020 Jun; 29(3):150920. PubMed ID: 32571505 [TBL] [Abstract][Full Text] [Related]
27. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation. Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013 [TBL] [Abstract][Full Text] [Related]
28. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer. Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328 [TBL] [Abstract][Full Text] [Related]
29. Treatment of refractory thyroid cancer. Berdelou A; Lamartina L; Klain M; Leboulleux S; Schlumberger M Endocr Relat Cancer; 2018 Apr; 25(4):R209-R223. PubMed ID: 29371330 [TBL] [Abstract][Full Text] [Related]
30. Approach to and treatment of differentiated thyroid carcinoma. Pacini F; Castagna MG Med Clin North Am; 2012 Mar; 96(2):369-83. PubMed ID: 22443981 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. Takami H; Ito Y; Okamoto T; Yoshida A World J Surg; 2011 Jan; 35(1):111-21. PubMed ID: 21042913 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma: The First Report in Nonwestern Countries. Joung JY; Choi JH; Cho YY; Kim NK; Sohn SY; Kim SW; Chung JH Am J Clin Oncol; 2016 Aug; 39(4):374-8. PubMed ID: 24732812 [TBL] [Abstract][Full Text] [Related]
33. Thyroid carcinoma in childhood: management and follow up of 11 cases. Jocham A; Joppich I; Hecker W; Knorr D; Schwarz HP Eur J Pediatr; 1994 Jan; 153(1):17-22. PubMed ID: 8313918 [TBL] [Abstract][Full Text] [Related]
34. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. Yildirim E J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848 [TBL] [Abstract][Full Text] [Related]
35. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. Mazzaferri EL; Kloos RT J Clin Endocrinol Metab; 2001 Apr; 86(4):1447-63. PubMed ID: 11297567 [No Abstract] [Full Text] [Related]
36. [Poorly differentiated thyroid carcinomas: new therapeutic considerations]. Graf H Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):711-8. PubMed ID: 16444353 [TBL] [Abstract][Full Text] [Related]
37. The role of total thyroidectomy in the management of differentiated thyroid cancer. Stephenson BM; Wheeler MH; Clark OH Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009 [TBL] [Abstract][Full Text] [Related]
38. Potential Impact of BMI on the Aggressiveness of Presentation and Clinical Outcome of Differentiated Thyroid Cancer. Matrone A; Ceccarini G; Beghini M; Ferrari F; Gambale C; D'Aqui M; Piaggi P; Torregrossa L; Molinaro E; Basolo F; Vitti P; Santini F; Elisei R J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31875910 [TBL] [Abstract][Full Text] [Related]
39. Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer-a retrospective analysis. Muller S; Senne M; Kirschniak A; Königsrainer A; Bares R; Falch C World J Surg Oncol; 2017 Oct; 15(1):190. PubMed ID: 29065879 [TBL] [Abstract][Full Text] [Related]